TrialClinical pharmacology in drug development2026

Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160-mg Tablet: Results From 2 Phase 1 Studies in Healthy Volunteers.

Bilal Tariq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.